首页> 外文期刊>British journal of ophthalmology >Transforming growth factor beta isoforms in human optic nerve heads (see comments)
【24h】

Transforming growth factor beta isoforms in human optic nerve heads (see comments)

机译:人类视神经头部中的转化生长因子β亚型(参见评论)

获取原文
获取原文并翻译 | 示例
       

摘要

AIM: To determine if the isoforms of transforming growth factor beta (TGF-beta) are present in fetal, normal adult, and glaucomatous optic nerve heads. METHODS: To localise cells synthesising TGF-beta, optic nerve heads were stained using antibodies to TGF-beta 1, TGF-beta 2, and TGF-beta 3. To demonstrate synthesis, human optic nerve heads from fetal, glaucomatous, and normal age matched subjects were explanted, cultured overnight, and the culture supernatant was assayed for the presence of TGF-beta 1 and TGF-beta 2 by bioassay. In addition, semiquantitative RT-PCR was performed to determine the gene expression pattern of TGF-beta 2. RESULTS: Immunohistochemistry of glaucomatous samples revealed the presence of intense staining for TGF-beta 2 primarily in astrocytes, whereas TGF-beta 1 was localised to blood vessels. No TGF-beta 3 immunoreactivity was observed. There was little or no expression of TGF-beta in normal optic nerve heads. Optic nerve heads from glaucomatous eyes released 70-100-fold more TGF-beta 2 than normal age matched optic nerve heads. Fetal optic nerve heads released 90-100-fold more TGF-beta 2 than normal adult optic nerve heads. TGF-beta 1 was undetectable by bioassay in all samples tested. There was no apparent increase in TGF-beta 2 gene expression in glaucomatous and fetal eyes, suggesting post-transcriptional regulatory mechanisms. CONCLUSIONS: These results demonstrate that TGF-beta 2 is produced in high levels in the fetal and glaucomatous optic nerve heads, perhaps by a mechanism of post-transcriptional regulation. TGF-beta may be important during development of the optic nerve head and, in glaucoma, TGF-beta 2 may be a mediator of astrocyte reactivation and extracellular matrix remodelling in the lamina cribrosa.
机译:目的:确定在胎儿,正常成人和青光眼性视神经乳头中是否存在转化生长因子β(TGF-β)的同工型。方法:为了定位合成TGF-β的细胞,使用针对TGF-beta 1,TGF-beta 2和TGF-beta 3的抗体对视神经乳头进行染色。为了证明合成,胎儿,青光眼和正常年龄的人视神经乳头将匹配的受试者移出,培养过夜,并通过生物测定法测定培养上清液中TGF-β1和TGF-β2的存在。此外,进行了半定量RT-PCR以确定TGF-β2的基因表达模式。结果:青光眼样品的免疫组织化学显示,主要在星形胶质细胞中存在TGF-β2的强烈染色,而TGF-β1局限于血管。没有观察到TGF-β3免疫反应性。正常视神经乳头中很少或没有TGF-β的表达。与正常年龄相匹配的视神经头相比,来自青光眼的视神经头释放的TGF-beta 2多70-100倍。胎儿的视神经乳头释放的TGF-beta 2比正常的成人视神经乳头释放90-100倍。在所有测试样品中,都无法通过生物测定法检测到TGF-beta 1。在青光眼和胎儿眼中,TGF-β2基因表达没有明显增加,提示转录后调控机制。结论:这些结果表明,TGF-β2可能是通过转录后调节机制在胎儿和青光眼视神经元中高水平产生的。 TGF-β在视神经头发育过程中可能很重要,在青光眼中,TGF-β2可能是筛板中星形胶质细胞激活和细胞外基质重塑的介体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号